ProPhase Labs, Inc. (PRPH) News
Filter PRPH News Items
PRPH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest PRPH News From Around the Web
Below are the latest news stories about PROPHASE LABS INC that investors may wish to consider to help them evaluate PRPH as an investment opportunity.
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call TranscriptProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript November 9, 2023 ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.2. Operator: Good day and welcome the ProPhase Labs Incorporated Third Quarter 2023 Financial Results and Corporate Update. All participants will be in listen-only mode. [Operator Instructions] After today’s […] |
ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic TransformationsFinancial and Operational Highlights for the Third Quarter of 2023 |
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from $10 million to over $75 million in 2024 Indications of demand for entire planned capacity expansion Nebula Genomics opens new, state of the art Whole Genome Sequencing lab in Garden City, NY. Strong indications for demand lead to significant planned capacity expansion. Company to hold a conference call Thursday, November 9, 2023, at 11:00 AM ET G |
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern TimeGARDEN CITY, NY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursday, November 9, 2023, at 11:00 a.m. Eastern time to discuss its results for the third quarter ended September 30, 2023 and provide a business update. A press release detailing these results will be issued prior to the call. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus, will h |
ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.Pharmaloz plan is to build capacity with a goal to attain a revenue run-rate of $60 to $80 million by year-end 2024, with 20-25% pre-tax net margins and a goal for additional growth thereafter. Garden City, NY, Oct. 17, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today unveiled the substantial expansion strategy for its wholly-owned subsidiary, Pharmaloz Manufacturing, Inc. (PMI). Pharmaloz is a large loz |
DSS Inc. Issues Letter to ShareholdersCEO Highlights Expected IPO of Impact Biomedical and Progress in SubsidiariesROCHESTER, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that it has issued a Letter to Shareholders. Dear Valued Shareholders, On behalf of the management team at DSS, Inc., I am pleased to provi |
ProPhase Labs to Present at The ThinkEquity ConferenceGARDEN CITY, NY, Oct. 12, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today announced it will be participating in The ThinkEquity Conference, which will take place on October 19, 2023 at The Mandarin Oriental Hotel in New York. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus will be presenting at 11:30 AM ET on October 19th. Interested parties can register to attend here: https://www |
Are ProPhase Labs, Inc. (NASDAQ:PRPH) Investors Paying Above The Intrinsic Value?Key Insights The projected fair value for ProPhase Labs is US$3.39 based on Dividend Discount Model ProPhase Labs is... |
ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.Garden City, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) Conference Call and Webcast Details Management will host a conference call at 11:00 AM ET, Thursday, August 10, 2023, to provide an update on corporate developments and review financial results. Following management’s formal remarks, there will be a question-and-answer session. Participants can register for the conference call by navigating to: https://dpregister.com/sreg/10181498/fa179afdde Please note that re |
ProPhase Labs, Inc. (PRPH) Reports Q2 Loss, Lags Revenue EstimatesProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of -42.86% and 6.69%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? |